We are live on
!
Find out more
LSC
Lyon Street Capital Portfolio holdings
AUM
$67M
This Fund
S&P 500
This Quarter
Est. Return
+9.84%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$161M
AUM Growth
-$121M
(-43%)
Cap. Flow
-$140M
Cap. Flow
% of AUM
-87.38%
Top 10 Holdings %
Top 10 Hldgs %
59.62%
Holding
61
New
9
Increased
5
Reduced
31
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DMC Global
BOOM
|
+$4.61M |
| 2 |
HPR
HighPoint Resources Corporation
HPR
|
+$2.23M |
| 3 |
SKX
Skechers
SKX
|
+$1.92M |
| 4 |
BAND
Bandwidth Inc
BAND
|
+$1.53M |
| 5 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
+$806K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
|
+$36.8M |
| 2 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$10.1M |
| 3 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$8.73M |
| 4 |
HDP
Hortonworks, Inc.
HDP
|
+$6.5M |
| 5 |
Savara
SVRA
|
+$6.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.14% |
| 2 | Technology | 23.24% |
| 3 | Financials | 10.7% |
| 4 | Communication Services | 8.76% |
| 5 | Consumer Discretionary | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STML
1
DELISTED
Stemline Therapeutics, Inc.
STML
| $24.1M | 15.01% |
1,451,700
-19,818
| -1% | -$318K |
|
|
BFYT
2
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $15.3M | 9.53% |
248,245
-808,025
| -76% | -$36.8M |
|
|
SBBP
3
DELISTED
Strongbridge Biopharma plc.
SBBP
| $13.9M | 8.63% |
2,858,928
-1,706,705
| -37% | -$8.73M |
|
|
CARB
4
DELISTED
Carbonite Inc
CARB
| $7.54M | 4.7% |
211,530
-30,361
| -13% | -$1.17M |
|
|
QTNA
5
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $6.88M | 4.28% |
372,725
-125,158
| -25% | -$2.13M |
|
|
6
Savara
SVRA
$1.13B
| $6.37M | 3.97% |
571,142
-563,274
| -50% | -$6.48M |
|
|
MODN
7
DELISTED
MODEL N, INC.
MODN
| $6.21M | 3.87% |
391,590
-330,912
| -46% | -$5.79M |
|
|
SGI
8
Somnigroup International
SGI
$15.1B
| $5.68M | 3.54% |
429,672
-126,300
| -23% | -$1.69M |
|
|
9
DMC Global
BOOM
$121M
| $5.09M | 3.17% |
124,882
+108,100
| +644% | +$4.61M |
|
10
Upland Software
UPLD
$12M
| $4.7M | 2.93% |
14,558
-8,169
| -36% | -$2.83M |
|
|
HDP
11
DELISTED
Hortonworks, Inc.
HDP
| $4.67M | 2.91% |
204,885
-311,567
| -60% | -$6.5M |
|
12
Box
BOX
$4.02B
| $3.79M | 2.36% |
158,406
-39,206
| -20% | -$987K |
|
|
GTT
13
DELISTED
GTT Communications, Inc.
GTT
| $3.52M | 2.19% |
81,060
-29,669
| -27% | -$1.27M |
|
14
Forestar Group
FOR
$1.44B
| $3.06M | 1.91% |
144,364
-58,834
| -29% | -$1.39M |
|
|
SREV
15
DELISTED
ServiceSource International, Inc.
SREV
| $3.03M | 1.89% |
1,063,786
+40,678
| +4% | +$135K |
|
16
QuinStreet
QNST
$870M
| $2.94M | 1.83% |
216,629
-44,256
| -17% | -$627K |
|
17
Ligand Pharmaceuticals
LGND
$6.02B
| $2.54M | 1.58% |
14,863
-36,414
| -71% | -$5.49M |
|
18
ICU Medical
ICUI
$3.93B
| $2.49M | 1.55% |
8,798
-11,202
| -56% | -$3.28M |
|
19
Grand Canyon Education
LOPE
$3.71B
| $2.45M | 1.53% |
21,749
-15,100
| -41% | -$1.76M |
|
20
FIVE9
FIVN
$1.77B
| $2.44M | 1.52% |
55,888
-55,929
| -50% | -$2.31M |
|
21
Tyler Technologies
TYL
$12.2B
| $2.38M | 1.48% |
9,709
-642
| -6% | -$153K |
|
22
Calix
CALX
$2.27B
| $2.26M | 1.41% |
278,623
+87,737
| +46% | +$670K |
|
|
SUP
23
DELISTED
Superior Industries International
SUP
| $2.17M | 1.35% |
127,585
+11,603
| +10% | +$223K |
|
|
BEAT
24
DELISTED
BioTelemetry, Inc.
BEAT
| $2.02M | 1.26% |
31,293
-181,341
| -85% | -$10.1M |
|
|
HPR
25
DELISTED
HighPoint Resources Corporation
HPR
| $1.91M | 1.19% |
+7,819
| New | +$2.23M |
|
Similar funds
DCM
SCMU
TLCM
EA
A
AAI
EM
ALFA
Lyon Street Capital's Q3 2018 Portfolio in Review
As of Q3 2018, Lyon Street Capital held 61 positions worth $161M, down 43% from $281M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Lyon Street Capital withdrew a net $140M in Q3 2018, closing 16 positions and reducing 31 holdings. Its most notable exit was Assembly Biosciences, an estimated $5.89M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 38% a quarter earlier, followed by Technology and Financials.
Against the trend, Lyon Street Capital opened a new position in HighPoint Resources Corporation worth $1.91M.
- Lyon Street Capital's largest Q3 2018 buy was HighPoint Resources Corporation: 7,819 shares worth $1.91M.
- Lyon Street Capital added most to DMC Global in Q3 2018, an estimated $4.61M increase.
- Lyon Street Capital's biggest Q3 2018 reduction was Benefytt Technologies, Inc. Class A Common Stock, cutting an estimated $36.8M.
- Lyon Street Capital fully exited Assembly Biosciences in Q3 2018, selling an estimated $5.89M.
- Lyon Street Capital's ten largest holdings make up 60% of its $161M portfolio in Q3 2018.
- Lyon Street Capital opened 9 new positions and closed 16 in Q3 2018.
- Lyon Street Capital's portfolio value fell 43% quarter-over-quarter to $161M.
Based on Lyon Street Capital's 13F filing for Q3 2018, filed 14 Nov 2018.